Haroutunian V

References (16)

Title : 82-kDa choline acetyltransferase is in nuclei of cholinergic neurons in human CNS and altered in aging and Alzheimer disease - Gill_2007_Neurobiol.Aging_28_1028
Author(s) : Gill SK , Ishak M , Dobransky T , Haroutunian V , Davis KL , Rylett RJ
Ref : Neurobiology of Aging , 28 :1028 , 2007
Abstract :
PubMedSearch : Gill_2007_Neurobiol.Aging_28_1028
PubMedID: 16797789

Title : Dissociation of neuropathology from severity of dementia in late-onset Alzheimer disease - Prohovnik_2006_Neurology_66_49
Author(s) : Prohovnik I , Perl DP , Davis KL , Libow L , Lesser G , Haroutunian V
Ref : Neurology , 66 :49 , 2006
Abstract :
PubMedSearch : Prohovnik_2006_Neurology_66_49
PubMedID: 16401845

Title : Mitochondrial abnormalities in Alzheimer brain: mechanistic implications - Bubber_2005_Ann.Neurol_57_695
Author(s) : Bubber P , Haroutunian V , Fisch G , Blass JP , Gibson GE
Ref : Annals of Neurology , 57 :695 , 2005
Abstract :
PubMedSearch : Bubber_2005_Ann.Neurol_57_695
PubMedID: 15852400

Title : p-Chloroamphetamine blocks physostigmine-induced memory enhancement in rats with unilateral nucleus basalis lesions - Santucci_2004_Pharmacol.Biochem.Behav_77_59
Author(s) : Santucci AC , Haroutunian V
Ref : Pharmacol Biochem Behav , 77 :59 , 2004
Abstract :
PubMedSearch : Santucci_2004_Pharmacol.Biochem.Behav_77_59
PubMedID: 14724042

Title : Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy body diseases - Perry_2000_Eur.J.Pharmacol_393_215
Author(s) : Perry E , Martin-Ruiz C , Lee M , Griffiths M , Johnson M , Piggott M , Haroutunian V , Buxbaum JD , Nasland J , Davis K , Gotti C , Clementi F , Tzartos SJ , Cohen O , Soreq H , Jaros E , Perry R , Ballard C , McKeith I , Court J
Ref : European Journal of Pharmacology , 393 :215 , 2000
Abstract :
PubMedSearch : Perry_2000_Eur.J.Pharmacol_393_215
PubMedID: 10771016

Title : Cholinergic markers in elderly patients with early signs of Alzheimer disease [see comments] - Davis_1999_Jama_281_1401
Author(s) : Davis KL , Mohs RC , Marin D , Purohit DP , Perl DP , Lantz M , Austin G , Haroutunian V
Ref : Jama , 281 :1401 , 1999
Abstract :
PubMedSearch : Davis_1999_Jama_281_1401
PubMedID: 10217056

Title : Pharmacological modulation of Alzheimer's beta-amyloid precursor protein levels in the CSF of rats with forebrain cholinergic system lesions - Haroutunian_1997_Brain.Res.Mol.Brain.Res_46_161
Author(s) : Haroutunian V , Greig N , Pei XF , Utsuki T , Gluck R , Acevedo LD , Davis KL , Wallace WC
Ref : Brain Research Mol Brain Res , 46 :161 , 1997
Abstract :
PubMedSearch : Haroutunian_1997_Brain.Res.Mol.Brain.Res_46_161
PubMedID: 9191090

Title : Cortical cholinergic markers in schizophrenia - Haroutunian_1994_Schizophr.Res_12_137
Author(s) : Haroutunian V , Davidson M , Kanof PD , Perl DP , Powchik P , Losonczy M , McCrystal J , Purohit DP , Bierer LM , Davis KL
Ref : Schizophr Res , 12 :137 , 1994
Abstract :
PubMedSearch : Haroutunian_1994_Schizophr.Res_12_137
PubMedID: 8043524

Title : Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease - Perry_1994_Neuroreport_5_747
Author(s) : Perry EK , Haroutunian V , Davis KL , Levy R , Lantos P , Eagger S , Honavar M , Dean A , Griffiths M , McKeith IG , et al.
Ref : Neuroreport , 5 :747 , 1994
Abstract :
PubMedSearch : Perry_1994_Neuroreport_5_747
PubMedID: 8018843

Title : Cholinergic marker deficits induced by lesions of the nucleus basalis of Meynert are attenuated by nerve growth factor in young, but not in aged, F344 rats - Santucci_1993_Brain.Res_609_327
Author(s) : Santucci AC , Kanof PD , Haroutunian V
Ref : Brain Research , 609 :327 , 1993
Abstract :
PubMedSearch : Santucci_1993_Brain.Res_609_327
PubMedID: 8508314

Title : Amyloid precursor protein in the cerebral cortex is rapidly and persistently induced by loss of subcortical innervation - Wallace_1993_Proc.Natl.Acad.Sci.U.S.A_90_8712
Author(s) : Wallace W , Ahlers ST , Gotlib J , Bragin V , Sugar J , Gluck R , Shea PA , Davis KL , Haroutunian V
Ref : Proc Natl Acad Sci U S A , 90 :8712 , 1993
Abstract :
PubMedSearch : Wallace_1993_Proc.Natl.Acad.Sci.U.S.A_90_8712
PubMedID: 8378353

Title : Induction of memory and cortical cholinergic neurochemical recovery with combine fetal transplantation and GM1 treatments in rats with lesions of the NBM - Santucci_1993_Dementia_4_273
Author(s) : Santucci AC , Gluck R , Kanof PD , Haroutunian V
Ref : Dementia , 4 :273 , 1993
Abstract :
PubMedSearch : Santucci_1993_Dementia_4_273
PubMedID: 8261024

Title : Restoration of cholinomimetic activity by clonidine in cholinergic plus noradrenergic lesioned rats - Haroutunian_1990_Brain.Res_507_261
Author(s) : Haroutunian V , Kanof PD , Tsuboyama G , Davis KL
Ref : Brain Research , 507 :261 , 1990
Abstract :
PubMedSearch : Haroutunian_1990_Brain.Res_507_261
PubMedID: 2110845

Title : Implications of multiple transmitter system lesions for cholinomimetic therapy in Alzheimer's disease -
Author(s) : Haroutunian V , Santucci AC , Davis KL
Ref : Prog Brain Res , 84 :333 , 1990
PubMedID: 1980019

Title : 9-Amino-1,2,3,4-tetrahydroacridin-1-ols: synthesis and evaluation as potential Alzheimer's disease therapeutics - Shutske_1989_J.Med.Chem_32_1805
Author(s) : Shutske GM , Pierrat FA , Kapples KJ , Cornfeldt ML , Szewczak MR , Huger FP , Bores GM , Haroutunian V , Davis KL
Ref : Journal of Medicinal Chemistry , 32 :1805 , 1989
Abstract :
PubMedSearch : Shutske_1989_J.Med.Chem_32_1805
PubMedID: 2754707

Title : (+\/-)-9-Amino-1,2,3,4-tetrahydroacridin-1-ol. A potential Alzheimer's disease therapeutic of low toxicity -
Author(s) : Shutske GM , Pierrat FA , Cornfeldt ML , Szewczak MR , Huger FP , Bores GM , Haroutunian V , Davis KL
Ref : Journal of Medicinal Chemistry , 31 :1278 , 1988
PubMedID: 3385720